Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
City of Hope Medical Center
Children's Oncology Group
Emory University
Nationwide Children's Hospital
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Augusta University
Hoffmann-La Roche
University of Florida
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of California, San Francisco
Duke University
Children's Oncology Group
British Columbia Cancer Agency
Pfizer
Hospital Infantil Universitario Niño Jesús, Madrid, Spain